Please login to the form below

Not currently logged in
Email:
Password:

Sanofi Genzyme

This page shows the latest Sanofi Genzyme news and features for those working in and with pharma, biotech and healthcare.

European Commission approves potential new treatment for Pompe disease

European Commission approves potential new treatment for Pompe disease

The European Commission (EC) has issued a marketing authorisation for Sanofi Genzyme’s therapy Nexviadyme (avalglucosidase alfa) for the long-term treatment of both late-onset and infantile-onset Pompe disease. ... In November 2021, Sanofi announced

Latest news

More from news
Approximately 18 fully matching, plus 80 partially matching documents found.

Latest Intelligence

  • Sourcing R&D innovation: why pharma companies need to evolve their business models Sourcing R&D innovation: why pharma companies need to evolve their business models

    One example is Genzyme (now Sanofi Genzyme), a pioneer in the rare disease space with a focus on R&D efforts targeting enzyme replacement therapies for lysosomal storage disorders and leading ... including Shire/Takeda, Actelion/J&J, Sanofi Genzyme,

  • Case study: See Below Case study: See Below

    Client:Sanofi Genzyme and Regeneron. Agency:Havas Lynx Group. Campaign:See Below. Timescale:N/A. Atopic dermatitis affects approximately 1-3% of adults worldwide. ... Topical corticosteroids are commonly used to treat atopic dermatitis. Sanofi Genzyme

  • Case study: OptiMiSe for MS nurses Case study: OptiMiSe for MS nurses

    Client:Sanofi Genzyme. Agency:Vivid – A Lucid Group Company. Campaign:OptiMiSe for MS nurses: a tailored, added-value support service for clinical behaviour change towards optimised services. ... It has also resulted in Sanofi Genzyme SOM-led support

  • Innovation and digital health comms recognised at Communiqué Awards Innovation and digital health comms recognised at Communiqué Awards

    Innovation in Healthcare Communications. One high profile winning campaign was Havas Lynx Group’s ‘See Below’ on behalf of Sanofi Genzyme and Regeneron.

  • Case study: The World vs MS Case study: The World vs MS

    Client:Sanofi Genzyme. Agency:H4B Manchester. Campaign:The World vs MS. Timescale:Ongoing. The World vs MS is an ongoing, ambitious social movement that has united the world in the fight ... As the world’s first pharma-sponsored emoji, it reinforces

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 12 partially matching documents found.

Latest from PMHub

  • Havas Lynx Group Havas Lynx Group

    AbbVie. ALK. Astellas. AstraZeneca. Bayer. Boehringer Ingelheim. BI. BMS. Celgene. Sanofi Genzyme. ... Sanofi. Siemens. Teva. UCB. ViiV.

  • Lucid Group are shortlisted in three categories for Communiqué 2020

    for Sanofi Genzyme. Category: The Real Science Award for Medical Affairs Agency of the Year.

  • Lucid Group make the cut at the PMEAs 2017

    OptiMiSe: a Multichannel Learning Platform for Clinical Behaviour Change Among Multiple Sclerosis Specialist Nurses, by Sanofi Genzyme, with support from Lucid Group.

  • Frontera Group Frontera Group

    Could mHealth save healthcare? The rare disease project has really transformed the Sanofi Genzyme rare disease franchise. ... Tom Rigden, Marketing Manager, Rare Disease Portfolio - Sanofi. "I had the pleasure of working with Frontera across a number of

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...
Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...